| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 04/27/2011 | EP2314601A1 Anti-inflammatory compounds and uses thereof |
| 04/27/2011 | EP2314593A1 Platelet ADP receptor inhibitors |
| 04/27/2011 | EP2314586A1 2-Acylaminothiazole derivative or salt thereof |
| 04/27/2011 | EP2314318A1 CD80 antibody for use in combination with chemotherapeutics to treat B cell malignancies |
| 04/27/2011 | EP2314315A1 A blocking monoclonal antibody to the human alpha1 I-domain of VLA-1, and its use for the treatment of inflammatory disorders |
| 04/27/2011 | EP2314301A2 Sensitization of chemotherapeutic agent-resistant neoplastic cells with various viruses |
| 04/27/2011 | EP2314293A1 Implantable device containing resorbable matrix material and rapamycin for preventing or treating vasuloproliferative diseases |
| 04/27/2011 | EP2313410A1 Imidazoquinazoline derivatives as anagrelide analogues for the treatment of myeloprolific diseases and thrombotic diseases |
| 04/27/2011 | EP2313084A1 An intrauterine delivery system for contraception |
| 04/27/2011 | EP1477175B1 Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient |
| 04/27/2011 | EP1197218B1 Algae protein polysaccharide extraction and use thereof |
| 04/27/2011 | CN1639317B Probiotic lactobacillus salivarius strains |
| 04/27/2011 | CN102036981A Substituted 4-hydroxypyrimidine-5-carboxamides |
| 04/27/2011 | CN102036978A Novel thiophenediamine derivative having urea structure |
| 04/27/2011 | CN102030709A Benzazepines compounds serving as vasopressin receptor antagonism |
| 04/27/2011 | CN102028939A Medicine with hirudin-containing active ingredient |
| 04/27/2011 | CN102028938A Medicament having effects of activating blood and dissolving stasis |
| 04/27/2011 | CN102028935A Method for forecasting, preventing and treating septicemia and septic shock and kit |
| 04/27/2011 | CN102028857A Blood-enriching beautifying beverage-removing paste and preparation method thereof |
| 04/27/2011 | CN102028828A Medical composite for treating benign prostatic hyperplasia and urodialysis and detection method of medical composite |
| 04/27/2011 | CN102028816A Chinese herbal medicinal compound preparation for treating hemorrhage disease of grass carp |
| 04/27/2011 | CN102028757A Processing method of mulberry composite extract |
| 04/27/2011 | CN102028730A Sea cucumber compound preparation, preparation method and usage formulation thereof |
| 04/27/2011 | CN102028719A Prescription mainly used for treating gynecological extreme tickle, superbug, severe anhydremia and intractable diseases |
| 04/27/2011 | CN102028712A Method for preparing enteric capsules by taking leech as raw material |
| 04/27/2011 | CN102028703A New application of inulin |
| 04/27/2011 | CN102028702A Application of compound of cation liposome and polydeoxyribonucleotide as medicament |
| 04/27/2011 | CN102028700A Medicinal composition and preparation method thereof |
| 04/27/2011 | CN102028661A Pegylated recombinant human granulocyte colony stimulating factor freeze-dried powder/injection and preparation method thereof |
| 04/27/2011 | CN102028647A Composition for relieving legs and preparation method thereof |
| 04/27/2011 | CN102027855A Technology for processing coastal glehnia root medicinal materials in planting and producing area and quality standard |
| 04/27/2011 | CN101669910B Preparation of cefobutazine sodium proliposome |
| 04/27/2011 | CN101514231B Fusion protein for resisting formation of thrombus targetedly and preparation method and application thereof |
| 04/27/2011 | CN101474151B Alkannin microemulsion composition |
| 04/27/2011 | CN101401891B Traditional Chinese medicine decoction for treating aplastic anemia |
| 04/27/2011 | CN101322811B Chinese medicine for treating epistaxis |
| 04/27/2011 | CN101274096B Stable Batroxobin medicament composition |
| 04/27/2011 | CN101176772B Pharmaceutical composition made of cattail pollen and safflower |
| 04/27/2011 | CN101085297B Traditional Chinese medicine freeze dried injection for curing cerebral infarction and preparation method thereof |
| 04/27/2011 | CN101062094B Total salvianolic acids long-cycle liposomes and the preparing method thereof |
| 04/27/2011 | CN101019645B Health food for remitting fatigue and raising hypoxia tolerance and its preparation method |
| 04/26/2011 | US7932376 Pyrimidine-based non-nucleotide composition and method for inhibiting platelet aggregation |
| 04/26/2011 | US7932355 Virally-safe factor VIII with a low content of higher multimers |
| 04/26/2011 | US7932278 2-aminoethoxyacetic acid derivatives and their use |
| 04/26/2011 | US7932273 3-[(2-{[4-(hexyloxycarbonylaminoiminomethyl) phenylamino]methyl}-1-methyl-1H-benzimidazol-5-carbonyl)pyridin-2-ylamino]propionic acid ethylester methansulfonate and its use as a medicament |
| 04/26/2011 | US7932253 Immunomodulating oxopyrrazolocinnolines as CD80 inhibitors |
| 04/26/2011 | US7931895 Monoclonal antibodies with enhanced ADCC function |
| 04/26/2011 | CA2483067C Method of forming iron hydroxypyrone compounds |
| 04/26/2011 | CA2467718C Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 04/26/2011 | CA2447999C Caspase inhibitors and uses thereof |
| 04/26/2011 | CA2446619C Permeation enhancers |
| 04/26/2011 | CA2446461C Substituted cyclohexane-1,4-diamine derivatives |
| 04/26/2011 | CA2424565C Novel crystalline forms of a factor xa inhibitor |
| 04/26/2011 | CA2423628C Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them |
| 04/26/2011 | CA2415397C Use of strains of parapoxvirus ovis for producing antiviral medicaments and medicaments against cancer |
| 04/26/2011 | CA2408838C Drug/drug delivery systems for the prevention and treatment of vascular disease |
| 04/26/2011 | CA2400871C Novel malconic acid derivatives, processes for their preparation, their use as inhibitor of factor xa activity and pharmaceutical compositions containing them |
| 04/26/2011 | CA2398497C Process for the preparation of acetyl-amidiniophenylalanyl-cyclohexylglycyl-pyridinioalaninamides |
| 04/26/2011 | CA2376064C Factor viia inhibitors |
| 04/26/2011 | CA2264012C Compositions and methods for polynucleotide delivery |
| 04/21/2011 | WO2011047262A2 Dual variable domain immunoglobulins and uses thereof |
| 04/21/2011 | WO2011047040A2 Methods and compositions to support transplanted tissue integration and innosculation with adipose stromal cells |
| 04/21/2011 | WO2011046954A1 Hematopoietic growth factor mimetic small molecule compounds and their uses |
| 04/21/2011 | WO2011046568A1 Compositions and methods of treatment of black hemophiliac patients |
| 04/21/2011 | WO2011046221A1 INTERFERON-α MODULATOR |
| 04/21/2011 | WO2011045811A1 Fused thiazolo and oxazolo pyrimidinones |
| 04/21/2011 | WO2011044742A1 Medicaments for inhibiting thrombosis |
| 04/21/2011 | WO2010141949A3 Urea sorbent |
| 04/21/2011 | US20110092669 Synthesis of cyclosporin analogs |
| 04/21/2011 | US20110092576 Synthetic phosphodiester oligonucleotides and therapeutical uses thereof |
| 04/21/2011 | US20110092561 Benzoisoindole derivatives for the treatment of pain |
| 04/21/2011 | US20110092542 Methods for treating spinal cord injury with a compound that inhibits a ncca-atp channel |
| 04/21/2011 | US20110092506 Trisubstituted amine compound |
| 04/21/2011 | US20110092496 Thiophene compounds and thrombopoietin receptor activators |
| 04/21/2011 | US20110092492 Imidazo compounds |
| 04/21/2011 | US20110092474 Diamino-pyridine, pyrimidine, and pyrazine modulators of the histamine H4 receptor |
| 04/21/2011 | US20110092468 Pharmaceutical Calcimimetics |
| 04/21/2011 | US20110092429 Compositions and methods for producing gamma-carboxylated proteins |
| 04/21/2011 | US20110092428 Detecting and controlling abnormal hematopoiesis |
| 04/21/2011 | US20110092420 Selenium containing modifying agents and conjugates |
| 04/21/2011 | US20110092412 Method of producing tat-hoxb4h |
| 04/21/2011 | US20110091570 Compositions and Devices for Antisepsis and Anticoagulation |
| 04/21/2011 | US20110091543 Oral delivery of modified transferrin fusion proteins |
| 04/21/2011 | US20110091542 Baclofen and r-baclofen gastroretentive drug delivery systems |
| 04/21/2011 | US20110091538 Polymer adapted to release bioactive agents in vivo, pharmaceutical composition and method of preparation thereof |
| 04/21/2011 | US20110091535 Solid pharmaceutical formulation |
| 04/21/2011 | US20110091534 Compositions comprising polymeric micelles for drug delivery |
| 04/21/2011 | US20110091508 Oligofluorinated cross-linked polymers and uses thereof |
| 04/21/2011 | US20110091506 Vaccine compositions |
| 04/21/2011 | US20110091483 Canine Anti-CD20 Antibodies |
| 04/21/2011 | US20110091472 Compositions for treating psoriasis |
| 04/21/2011 | US20110091469 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
| 04/21/2011 | US20110091465 Polypeptides |
| 04/21/2011 | US20110091463 Dual Variable Domain Immunoglobulins and Uses Thereof |
| 04/21/2011 | US20110091450 Methods for treating disseminated intravascular coagulation by inhibiting masp-2 dependent complement activation |
| 04/21/2011 | US20110091442 Novel compositions for preventing and/or treating lysosomal storage disorders |
| 04/21/2011 | US20110091426 Human brain endothelial cells and growth medium and method for expansion of primitive CD34+CD38- bone marrow stem cells |
| 04/21/2011 | US20110091415 Hydroxyethyl Starch-Containing Polypeptide Compositions |
| 04/21/2011 | US20110091379 Method for treating tumors and their metastases |
| 04/21/2011 | DE102009049679A1 Pyrazolopyrimidinderivate Pyrazolopyrimidinderivate |